News

Early transcatheter aortic valve replacement reduces cardiovascular events in asymptomatic aortic stenosis patients
New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...
Single antiplatelet therapy reduced risk in patients undergoing transcatheter aortic valve replacement by half
Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that ...
MassDevice1d
Edwards wins FDA nod for TAVR in aortic stenosis without symptoms
Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.
Healio1d
FDA approves first TAVR platform to treat severe asymptomatic aortic stenosis
Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...
TCTMD1d
FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis
The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.
MedPage Today on MSN1d
FDA Approves Sapien 3 TAVR for Asymptomatic Aortic Stenosis
FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...
Medical Device Network on MSN1d
FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients
Edwards’ SAPIEN 3 platform becomes the first TAVR system approved by the FDA for asymptomatic severe aortic stenosis patients ...
Scientists develop a new model to study hypertension and aortic aneurysms
Oxidative stress can occur when our cells are exposed to harmful molecules called "reactive oxygen species" over time. These ...
BioWorld1d
FDA expands Edwards’ TAVR to asymptomatic severe aortic stenosis
In a significant boost to the Edwards Lifesciences Corp. Sapien 3 platform’s market opportunity, the U.S. FDA approved use of the transcatheter aortic valve replacement in patients with asymptomatic ...
Johns Hopkins Medicine3d
Novel Bone Marrow Transplant Can Cure Sickle Cell Disease
Outside magazine The idea behind sleepmaxxing — getting sufficient, good quality sleep — isn’t new, says Aruna Rao, assistant professor of neurology at Johns Hopkins Medicine. “People are finally ...